Stockreport

Lineage Cell Therapeutics Enters Into Three Separate License Agreements for Certain Intellectual Property and Assets

Lineage Cell Therapeutics, Inc.  (LCTX) 
PDF CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cellular t [Read more]